Avoiding Harm From Hyperbilirubinemia Screening-Reply
- PMID: 31589244
- PMCID: PMC7203610
- DOI: 10.1001/jamapediatrics.2019.3762
Avoiding Harm From Hyperbilirubinemia Screening-Reply
Conflict of interest statement
Comment on
-
Screening for Neonatal Hyperbilirubinemia-First Do No Harm?JAMA Pediatr. 2019 Jul 1;173(7):617-618. doi: 10.1001/jamapediatrics.2019.1194. JAMA Pediatr. 2019. PMID: 31107538 Free PMC article. Review. No abstract available.
-
Avoiding Harm From Hyperbilirubinemia Screening.JAMA Pediatr. 2019 Dec 1;173(12):1209. doi: 10.1001/jamapediatrics.2019.3765. JAMA Pediatr. 2019. PMID: 31589245 No abstract available.
-
Avoiding Harm From Hyperbilirubinemia Screening.JAMA Pediatr. 2019 Dec 1;173(12):1208-1209. doi: 10.1001/jamapediatrics.2019.3759. JAMA Pediatr. 2019. PMID: 31589273 No abstract available.
References
-
- Calonge N, Green NS, Rinaldo P, et al.; Advisory Committee on Heritable Disorders in Newborns and Children. Committee report: method for evaluating conditions nominated for population-based screening of newborns and children. Genet Med. 2010;12(3):153–159. doi:10.1097/GIM.0b013e3181d2af04 - DOI - PubMed
-
- Kemper AR, Green NS, Calonge N, et al. Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children. Genet Med. 2014;16(2):183–187. doi:10.1038/gim.2013.98 - DOI - PubMed
